Pfizer (PFE) in Global Blood Therapeutics (GBT) Takeover Talks
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
Go back to Pfizer (PFE) in Global Blood Therapeutics (GBT) Takeover Talks
August 8, 2022 4:19 PM EDT
RBC Capital analyst Gregory Renza downgraded Global Blood Therapeutics (NASDAQ: GBT) from Outperform to Sector Perform with a price target of $68.50 (from $60.00).
The analyst comments "Srong Oxbryta revenue beat for 2Q22 and the PFE acquisition underscore the strong fundamentals... More
August 5, 2022 11:54 AM EDT
Pfizer (NYSE: PFE) is reportedly in advanced talks to acquire Global Blood Therapeutics (NYSE: GBT), according to a report by The Wall Street Journal Friday.
The news follows Thursday's report by Bloomberg that large pharmaceutical companies... More
August 5, 2022 11:36 AM EDT
Global Blood Therapeutics (NASDAQ: GBT) halted on volatility amid deal reports
...
More
August 5, 2022 11:35 AM EDT
(Updated - August 5, 2022 11:35 AM EDT)
Pfizer (NYSE: PFE) is in advanced talks to buy Global Blood Therapeutics (NASDAQ: GBT) - WSJ
the deal is said to be around $5 billion....
More
August 5, 2022 2:31 AM EDT
Increasing unusual call option volume: GBT XP AES ITUB FAZE NSC EVFM
...
More
August 4, 2022 12:58 PM EDT
Large pharmaceutical companies are reportedly eyeing a potential takeover deal for Global Blood Therapeutics (NASDAQ: GBT), according to a Bloomberg report Thursday.
Citing people familiar with the matter, the report states biopharmaceutical firm Global Blood Therapeutics is working with advisors to study potential interest, although there is no certainty a takeover will occur.... More
